Hypertrophic Scarring After Facial Burn

Subjects with a burn to the face and/or neck will be enrolled into the study and a Three-Dimensional scanner used to see if it can objectively measure scar color and volume and measure the effect of scar on motion of the face and neck.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Burn Burns Wounds and Injuries

Age range

4 year–70 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Legacy Emanuel Hospital and Health Center

Portland, Oregon, 97227, United States

About this study

Subjects will have 11 clinic visits over a 2-year period. An initial scan of the subject's head and neck will be made. Ten reproducible landmarks on the face and neck will be determined. The subject will return for follow up scans at Day 14, Day 28 and Month 2,6,9,12,18 and 24.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Face and/or Neck Burn

Treatment and study plan

3-Dimensional Color Scanning

Device

Color imaging of the face and neck.

Other names: Cyberware 3030 RGB Color Scanner

Primary outcomes

Scar maturation

Time frame: 5.5 years

Can a 3-D scanner measure static and dynamic changes

Sponsors and collaborators

Lead sponsor

Legacy Health System

Other

Collaborators

Total Contact

Registry information

Official study title

Hypertrophic Scarring After Facial Burn: A Pilot, Observational Study of Static and Dynamic Measurements of Facial Scars With the 3-D Scanner Through the Scar Maturation Process

Important dates

Study start: 2005
Primary completion: 2011
Study completion: 2011
First posted: Oct 21, 2005
Registry last updated: Apr 3, 2015

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed